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ABSTRACT
Introduction Approximately 75% of mental disorders 
emerge before the age of 25 years but less than half 
receive appropriate treatment. Little is known about 
the mechanisms underlying the therapeutic change of 
adolescents in psychotherapy. The ‘European Network 
of Individualised Psychotherapy Treatment of Young 
People with Mental Disorders’, funded by the European 
Cooperation in Science and Technology, will conduct 
the first systematic review to summarise the existing 
knowledge on mediators and theories of change in 
psychotherapy for adolescents.
Method A systematic review will be conducted, 
conforming to the reporting guidelines of the Preferred 
Reporting Items for Systematic Reviews and Meta- 
Analyses statement recommendations. Electronic 
databases (PubMed and PsycINFO) have been 
systematically searched on 23 February 2020, for 
prospective, longitudinal and case- control designs 
which examine mediators of change. Participants will 
be adolescents between 10 and 19 years of age who 
suffer from a mental disorder or psychological difficulties 
and receive an intervention that aims at preventing, 
ameliorating and/or treating psychological problems.
Ethics and dissemination Ethical approval is not 
required for this systematic review as no primary data 
will be collected. The results will be published in a peer- 
reviewed journals and at conference presentations and 
will be shared with stakeholder groups. The whole data 
set will be offered to other research groups following 
recommendations of the open science initiative. Databases 
with the systematic search will be made openly available 
following open science initiatives.
PROSPERO registration number CRD42020177535.
INTRODUCTION
Adolescents and young adults are a particu-
larly important and vulnerable group with 
distinct mental health needs. According to 
Kessler et al, 50% of lifetime diagnosable 
mental health disorders start by the age of 
14, and this number increases to 75% by 
the age of 25.1 2 Ignoring young people’s 
mental health needs can result in long- lasting 
adverse developmental outcomes for the indi-
vidual and society. These include: psychiatric 
disorders in adulthood, impaired social func-
tioning, difficulties with employment as well 
as poorer general health outcomes.3
Psychotherapy is effective, efficient and cost- 
effective, providing long- term impacts which 
are not possible with psychopharmacological 
treatment alone.4–6 There is strong evidence 
on the general effectiveness of psychotherapy 
for treating mental disorders in adoles-
cents,7 8 and a wealth of psychotherapy treat-
ment modalities are currently being used 
and researched, with >550 different psycho-
therapy models that can be applied to young 
people.9 Treatment response is explained 
by different mechanisms of change and 
accounted for by a variety of mediators (eg, 
self- reflection, learning compensatory skills, 
changing automatic thoughts and so on) 
Strengths and limitations of this study
 ► Review aims at identifying underlying mechanisms 
of change in the process of psychotherapy for 
adolescents.
 ► Reviewers are from a European multidisciplinary 
researcher network with researchers and clinicians 
from 30 countries.
 ► First comprehensive overview of mediators in psy-
chotherapy carried out with adolescents.
 ► Broad inclusion criteria increase external validity but 
limits the possibility of causal conclusions including 
non- randomised controlled trials studies, it is likely 
not feasible to estimate aggregated effect sizes for 
the identified mediators.
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associated with each treatment modality. While various 
psychotherapy modalities (eg, psychodynamic psycho-
therapy; cognitive behavioural therapy) have shown 
equally good treatment outcomes overall, adherence to a 
specific treatment modality has not shown to significantly 
impact the outcome in child and adolescent psycho-
therapy.10 However, to understand therapeutic change 
and enhance outcomes, it is necessary to identify treat-
ment processes or characteristics within the therapist, the 
adolescent, parent or family that facilitate successful ther-
apeutic change and isolate those that are redundant and 
can be dismissed.9 Thus, research on underlying specific 
mechanisms of change across treatment modalities and 
settings is essential to optimising treatment.
An important first step towards examination of mecha-
nisms of change in psychotherapy is the identification of 
mediators. While moderators (eg, gender, age) serve to 
clarify what kind of treatment is adequate for a specific 
person under certain circumstances, mechanisms of 
change define causal relationships between therapeutic 
change and psychological interventions. A mechanism 
of change explains how an intervention translates into a 
process that leads to an outcome, for example, change in 
symptoms.11 Thus, a mechanism is an explanatory concept 
that can be investigated by researching mediators, that 
is, variables that explain changes statistically. Kazdin has 
formulated clear criteria on how to assess mediators of 
psychological treatments12:
 ► Conduct sufficiently powered randomised clinical 
trials.
 ► Use valid and reliable measures for mediators that are 
sensitive to change.
 ► Apply a process design in which changes of the medi-
ator temporally precede changes in therapeutic 
outcome and the mediator variable is measured 
repeatedly.
 ► Compare mediators that are theory- driven with non- 
specific mediators.
 ► Apply different dosages to prove that a stronger 
mediator- change leads to more therapeutic changes.
However, even after 13 years of Kazdin’s suggestions on 
how to assess mechanisms of change in psychotherapy 
research,12 there are still an alarming lack of studies, 
inconclusive results (eg, the treatment of depression 
in adults)13 and very little research on change mech-
anisms for the treatment of adolescents.14 15 Cuijpers et 
al conclude that despite >70 years of systematic psycho-
therapy research, we have no empirically validated mech-
anisms of change in adult psychotherapy.16 The current 
systematic review will be the first to summarise the 
existing knowledge on mediators and theories of change 
in psychotherapy for adolescents.
To address these challenges related to mediators and 
measures of the mechanisms of change and therapies’ effi-
cacy in children and adolescents, besides other activities, 
the European Cooperation in Science and Technology 
(COST) funded a 4- year programme named ‘European 
Network of Individualised Psychotherapy Treatment of 
Young People with Mental Disorders’ (TREATme) ( www. 
treat- me. eu) that serves as a European multidisciplinary 
researcher network with researchers and clinicians from 
30 countries. TREATme will review the academic research 
relating to mechanisms of change in patients aged 
between 10 and 30 years receiving psychological treat-
ments. For the current review, the part of the collected 
data set concerning adolescents only will be used. The aim 
is to provide an overview of existing research on psycho-
logical factors that mediate psychotherapeutic change in 
adolescents. We will conduct a narrative synthesis of all 
studies available up to 2020. The objectives of this review 
are the following:
1. To identify which mediators and theories of change 
have been studied in psychotherapy with adolescents.
2. To identify if there are adolescence- specific, disorder- 
specific or treatment- specific mediators.
3. To critically evaluate the methodological approach of 
the current research data available on mediators in 
psychotherapy for adolescents.
In order to obtain a comprehensive overview of the 
field of psychotherapy for adolescents, we will include 
various forms of psychotherapy and quantitative research 
designs. We will select all studies including a statistical test 
of mediation (eg, Baron and Kenny or more advanced 
methods)17 and will summarise study characteristics and 
results. We will discuss the extent to which these studies 
meet the most important requirements for mediator 
research that were mentioned earlier. Furthermore, we 
will relate mediators to the respective theories of change 
and describe which mediators successfully explain thera-
peutic change. Ultimately, this review can contribute to 
the challenging process of identifying underlying mech-
anisms of change in the process of psychotherapy for 
adolescents.
METHOD
The review follows the Preferred Reporting Items for 
Systematic Review and Meta- Analysis Protocols.18 This 
article is based on work from the COST Action TREATme 
aiming to improve knowledge and understanding of 
psychotherapeutic interventions in young people. The 
patient/population, intervention, comparison and 
outcomes (PICO) model was used to define the research 
question.
Eligibility criteria
Studies from any geographical location, written in 
English, available as full- text and published from incep-
tion onwards until 23 February 2020 that meet criteria, 
will be included in the review. Grey literature such as 
theses, dissertations or conference proceedings will also 
be included.
Types of studies
Due to a lack of studies fulfilling all criteria for mediator 
research, we decided to include a broad range of study 
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types. Studies will be selected if they include statistical 
analysis of mediators in psychotherapy. This comprises 
(a) empirical quantitative studies following prospective, 
longitudinal and case- control designs, (b) terms related 
to or describing mediators and (c) a psychosocial inter-
vention and/or psychotherapeutic intervention or treat-
ment for primary/secondary prevention.
Types of participants
WHO defines adolescents as individuals between 10 and 
19 years of age,19 which was the age group selected for 
our inclusion criteria. These participants would have 
a mental disorder (eg, depression, eating disorders) or 
psychological difficulties (eg, binge drinking) and receive 
a psychotherapeutic intervention, including primary and 
secondary prevention programmes. All comparators will 
be included as we will be investigating mediators in all 
treatments and not the efficacy of one treatment over 
another.
Types of interventions
Studies will be included if they report an intervention 
aimed at preventing, ameliorating and/or treating 
psychological problems of adolescents by using psycho-
social mechanisms and strategies in any setting (ie, indi-
vidual, family, group, inpatients, eMental health and 
so on). These interventions should not be primarily 
biological or physiological. Examples of interventions 
include all branches or types of psychotherapy: psycho-
dynamic, integrative, systemic, cognitive- based or 
cognitive- behavioural, interpersonal, humanistic (such as 
emotion- focused, supportive, motivational interviewing), 
psychoeducation and third- wave approaches (such as 
mindfulness- based therapies).
Search strategy
The search strategy includes terms relating to or describing 
the intervention. These terms have been combined with 
the Cochrane MEDLINE filter for controlled trials of 
interventions and were adapted for PsycINFO.20 Studies 
published from inception to 23 February 2020 have been 
sought. The search string can be found in the online 
supplemental file 1. The search was performed on 23 
February 2020.
Data extraction
Study selection will be carried out by a group of 20 expe-
rienced researchers divided into 10 pairs who will inde-
pendently assess the eligibility of studies retrieved using 
the search strategy in two phases. The first phase comprises 
the screening of the titles and/or abstracts of studies that 
potentially meet the inclusion criteria outlined above. 
In the second phase, each pair of reviewers will evaluate 
the full text of these potentially eligible studies to see if 
they meet the inclusion criteria. Disagreements will be 
discussed by the pair, and a third reviewer will be involved 
if consensus cannot be reached. Finally, a fourth indepen-
dent reviewer will perform an additional quality control 
check by assessing the eligibility of every fifth excluded 
study. Disagreements at this stage will be solved through 
discussion with the original review pair.
Data records will be managed with the support of Micro-
soft Excel.21 A standardised form will be used to extract 
the information for the review. Extracted information 
will include: study setting; study population, participant 
demographics and baseline characteristics; details of the 
intervention and control conditions; study methodology; 
outcomes and times of measurement; assessed mediators; 
type of mediation analysis and information for assessment 
of the risk of bias. Two review authors will extract infor-
mation independently; discrepancies will be identified 
and resolved through discussion or with a third author 
when necessary.
Critical appraisal
Although no standard form for evaluating mediation 
studies has been established, studies will be checked 
against general criteria for identifying mediators of psycho-
social interventions in research, such as summarised by 
Kazdin12 and Lemmens et al.13
Data synthesis
We will provide a narrative synthesis of the findings from 
the included studies, with a focus on the categories of 
mediators that have been tested, types of psychosocial 
interventions that have been investigated and mental 
disorders or psychological difficulties of adolescents that 
have been treated. It will be discussed if age- specific, 
disorder- specific or treatment- specific mediators can be 
identified. The age- specific mediators will be identified 
by comparing results with mediators identified by reviews 
from adult psychotherapy.
Outcomes and prioritisation
The primary outcome will be mediators related to change 
in mental health problems or disorders in adolescents 
measured by a validated instrument or tool made for 
that purpose. Data on the disorder will be categorised 
into depression, anxiety, substance misuse, externalising 
problems, severe mental illness (eg, psychosis, bipolar 
disorder) and others (eg, eating disorders). The thera-
pies will be categorised into: psychodynamic, integra-
tive, systematic, cognitive- based or cognitive- behavioural, 
interpersonal, humanistic, psychoeducation and third- 
wave. Mediators and instruments for assessing them will 
be identified. The statistical analyses for evaluating the 
effect of mediators will be recorded. Pretreatment and 
post- treatment scores will be noted, and the differences 
compared.
Risk of bias in individual studies
The Mixed Methods Appraisal Tool will be used to eval-
uate the overall study quality using a formal risk of bias 
assessment.22 This tool permits the appraisal of the meth-
odological quality of five categories of studies: qualitative 
research, randomised controlled trials, non- randomised 
studies, quantitative descriptive studies and mixed 
methods studies.
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Patient and public involvement
No patient was involved in planning and conducting the 
study.
Ethics and dissemination
No ethical approval will be necessary to conduct the review 
as no additional empirical data will be assessed. Results 
from the review will be disseminated through a publica-
tion in a peer- reviewed open access journal and through 
scientific communication using the COST Action home-
page. The data set that will be established during the 
search and extractions will be published in an open data 
repository after the acceptance of the publication of the 
review order to facilitate access to students, academia and 
professionals. Additionally, results will be disseminated in 
conferences, seminars, congresses or symposia.
DISCUSSION
As far as the authors are aware, this is the first system-
atic review of its kind, assessing mediators of psychother-
apeutic changes in adolescents. The findings will inform 
how much is currently known about such mediators and 
the practical implications of this knowledge for treatment 
planning and outcomes. The results will also shed light 
on how these empirically studied mediators correspond 
with the theoretically putative mechanisms of change 
in particular models of intervention. Using qualitative 
synthesis, we will evaluate and comment on the conclu-
siveness of age- specific, disorder- specific or treatment- 
specific mediators and map out the most pressing needs 
for future research on mediators and mechanisms of 
change in adolescent psychotherapy. The review will 
provide a basis for comparing our results with those of 
systematic reviews in adults, to assess whether there are 
similar or different mediators in adolescents that explain 
therapeutic change.
The strengths of this protocol include the gathering of a 
large multidisciplinary group of international researchers 
with long- standing accumulated experience in the area 
that have worked on this topic for 3 years through regular 
online and face- to- face meetings. Furthermore, the 
group has consulted international experts in the field to 
develop the protocol. A structured quality assurance will 
be carried out, as well as several search updates to ensure 
the completeness of the data set. The whole data set will 
be offered to other research groups following the recom-
mendations of the open science initiative.
Limitations of this protocol include the use of broad 
inclusion criteria to describe the existing knowledge 
comprehensively and increase external validity, which 
likely limits the possibility of causal conclusions by also 
including non- randomised controlled trials. For the same 
reason, it is likely not feasible to estimate aggregated 
effect sizes for the identified mediators. Our conclusions 
on mechanisms of change will only be related to empir-
ical quantitative studies as we have excluded qualitative 
and theoretical studies. As there is no generally accepted 
gold standard for mediation analysis, we expect much 
variance in the studies, which could lead to our results 
being inconclusive or inconsistent. Also, we are analysing 
both subclinical conditions and diagnosable disorders, 
as well as intervention and prevention studies, which 
may lead to less consistent or coherent results. We have 
chosen to do this in order to address the adolescent age 
group holistically and aim to report the results separately 
in order to establish independent conclusions. As the 
rater team consists of a fairly large group, inter- rater bias 
has to be strictly monitored, and so a fourth independent 
reviewer will be introduced to perform additional quality 
control checks.
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